FY2017 Earnings Estimate for Smith & Nephew plc Issued By Northcoast Research (SNN)
Smith & Nephew plc (NYSE:SNN) – Northcoast Research decreased their FY2017 earnings per share estimates for shares of Smith & Nephew in a report released on Friday. Northcoast Research analyst D. Keiser now expects that the medical equipment provider will post earnings per share of $1.79 for the year, down from their previous estimate of $1.81. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2017 earnings at $0.93 EPS and FY2018 earnings at $1.85 EPS.
SNN has been the topic of several other research reports. Zacks Investment Research upgraded Smith & Nephew from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research report on Wednesday, October 18th. Morgan Stanley downgraded Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research report on Monday, December 11th. Finally, Canaccord Genuity reiterated a “buy” rating and set a $45.00 price objective on shares of Smith & Nephew in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $44.00.
Institutional investors have recently made changes to their positions in the stock. Bessemer Group Inc. lifted its position in Smith & Nephew by 400.2% during the third quarter. Bessemer Group Inc. now owns 2,781 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 2,225 shares in the last quarter. Lbmc Investment Advisors LLC purchased a new position in Smith & Nephew during the third quarter worth approximately $206,000. First Allied Advisory Services Inc. purchased a new position in Smith & Nephew during the third quarter worth approximately $247,000. Quantbot Technologies LP lifted its position in Smith & Nephew by 270.0% during the second quarter. Quantbot Technologies LP now owns 7,277 shares of the medical equipment provider’s stock worth $253,000 after buying an additional 5,310 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its position in Smith & Nephew by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 7,437 shares of the medical equipment provider’s stock worth $260,000 after buying an additional 63 shares in the last quarter. Hedge funds and other institutional investors own 6.39% of the company’s stock.
About Smith & Nephew
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.